Literature DB >> 2568911

Isolation of 10 cyclosporine metabolites from human bile.

C P Wang1, N R Hartman, R Venkataramanan, I Jardine, F T Lin, J E Knapp, T E Starzl, G J Burckart.   

Abstract

Ten metabolites of cyclosporine were isolate from the ethyl ether extract of bile from four liver transplant patients receiving cyclosporine. Two of the metabolites were unique and previously unidentified. Liquid-liquid partitioning into diethyl ether with subsequent defatting with n-hexane was used for the initial extraction from bile. Separation of the individual metabolites (A-J) was performed using a Sephadex LH-20 column and a gradient high performance liquid chromatographic method. The molecular weights of the isolated metabolites were determined by fast atom bombardment/mass spectrometry. Gas chromatography with mass spectrometric amino acid analysis was also used to identify the amino acid composition and the hydroxylation position of metabolites A, B, C, D, and G. Proton nuclear magnetic resonance spectra were utilized to distinguish the chemical shifts of N-CH3 singlets and NH doublets of metabolites A, B, C, and D. Metabolites A, E, F, H, I, and J were reported previously in human urine and animal bile. Metabolites C and D are dihydroxylated compounds which cannot be clearly described as previously isolated compounds. Metabolites B and G are novel metabolites with a mass fragment which corresponded to a loss of 131 Da from the protonated molecular ion (MH+) in the fast atom bombardment/mass spectrometry, suggesting that the double bond in amino acid 1 has been modified. Metabolites B and G were primarily isolated from the bile of one of the liver transplant patients which contained abnormally high concentrations of these two metabolites. The method described is an efficient procedure for isolating milligram quantities of the major metabolites with greater than 95% purity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568911      PMCID: PMC3154783     

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  14 in total

1.  Identification of the Aldehydic Metabolites.

Authors:  H Hashem; R Venkataramanan; G J Burckart; L Makowka; T E Starzl; E Fu; L K Wong
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

2.  Deposition of nine metabolites of cyclosporine in human tissues, bile, urine, and whole blood.

Authors:  G L Lensmeyer; D A Wiebe; I H Carlson
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

3.  Ciclosporin and its future.

Authors:  J F Borel
Journal:  Prog Allergy       Date:  1986

4.  Cyclosporine metabolite concentrations in the blood of liver, heart, kidney, and bone marrow transplant patients.

Authors:  C P Wang; G J Burckart; R J Ptachcinski; R Venkataramanan; T Schwinghammer; T Hakala; B Griffith; R Hardesty; R Shadduck; J Knapp
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

5.  Immunosuppressive effect of cyclosporine metabolites from human bile on alloreactive T cells.

Authors:  A Zeevi; G Eiras; G Burckart; L Makowka; R Venkataramanan; C P Wang; D H Van Thiel; N Murase; T E Starzl; R Duquesnoy
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

6.  Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites.

Authors:  G Maurer; H R Loosli; E Schreier; B Keller
Journal:  Drug Metab Dispos       Date:  1984 Jan-Feb       Impact factor: 3.922

7.  An acid metabolite of cyclosporine.

Authors:  N R Hartman; L A Trimble; J C Vederas; I Jardine
Journal:  Biochem Biophys Res Commun       Date:  1985-12-31       Impact factor: 3.575

Review 8.  Cyclosporine: the agent and its actions.

Authors:  B D Kahan
Journal:  Transplant Proc       Date:  1985-08       Impact factor: 1.066

9.  The in vitro activity, radioimmunoassay cross-reactivity, and molecular weight of thirteen rabbit cyclosporine metabolites.

Authors:  N R Hartman; I Jardine
Journal:  Drug Metab Dispos       Date:  1987 Sep-Oct       Impact factor: 3.922

10.  Mass spectrometric analysis of cyclosporine metabolites.

Authors:  N R Hartman; I Jardine
Journal:  Biomed Environ Mass Spectrom       Date:  1986-07
View more
  4 in total

Review 1.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.

Authors:  Hanene Eljebari; Emna Gaies; Nadia Ben Fradj; Nadia Jebabli; Issam Salouage; Sameh Trabelsi; Mohamed Lakhal; Anis Klouz
Journal:  Eur J Clin Pharmacol       Date:  2012-04-15       Impact factor: 2.953

3.  Des3PI: a fragment-based approach to design cyclic peptides targeting protein-protein interactions.

Authors:  Maxence Delaunay; Tâp Ha-Duong
Journal:  J Comput Aided Mol Des       Date:  2022-08-06       Impact factor: 4.179

4.  Human cytochrome P450 3A4: enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase.

Authors:  M S Shet; C W Fisher; P L Holmans; R W Estabrook
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.